These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 3146779
1. Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats. Mandel RJ, Thal LJ. Psychopharmacology (Berl); 1988; 96(3):421-5. PubMed ID: 3146779 [Abstract] [Full Text] [Related]
2. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers. Mandel RJ, Chen AD, Connor DJ, Thal LJ. J Pharmacol Exp Ther; 1989 Nov; 251(2):612-9. PubMed ID: 2810114 [Abstract] [Full Text] [Related]
3. The behavioral effects of heptylphysostigmine on rats lesioned in the nucleus basalis. Waite JJ, Thal LJ. Neurosci Res; 1995 Jan; 21(3):251-9. PubMed ID: 7753506 [Abstract] [Full Text] [Related]
4. Nucleus basalis lesions in neonate rats induce a selective cortical cholinergic hypofunction and cognitive deficits during adulthood. Sengstock GJ, Johnson KB, Jantzen PT, Meyer EM, Dunn AJ, Arendash GW. Exp Brain Res; 1992 Jan; 90(1):163-74. PubMed ID: 1521605 [Abstract] [Full Text] [Related]
5. Frontal cortex as the site of action of physostigmine in nbM-lesioned rats. Haroutunian V, Mantin R, Kanof PD. Physiol Behav; 1990 Jan; 47(1):203-6. PubMed ID: 2326337 [Abstract] [Full Text] [Related]
6. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems. Dekker AJ, Gage FH, Thal LJ. Neuroscience; 1992 Jan; 48(1):111-9. PubMed ID: 1374860 [Abstract] [Full Text] [Related]
7. Induction of memory and cortical cholinergic neurochemical recovery with combine fetal transplantation and GM1 treatments in rats with lesions of the NBM. Santucci AC, Gluck R, Kanof PD, Haroutunian V. Dementia; 1993 Jan; 4(5):273-81. PubMed ID: 8261024 [Abstract] [Full Text] [Related]
8. Chronic sparing of delayed alternation performance and choline acetyltransferase activity by CEP-1347/KT-7515 in rats with lesions of nucleus basalis magnocellularis. DiCamillo AM, Neff NT, Carswell S, Haun FA. Neuroscience; 1998 Sep; 86(2):473-83. PubMed ID: 9881862 [Abstract] [Full Text] [Related]
9. Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine. Murray CL, Fibiger HC. Neuroscience; 1985 Apr; 14(4):1025-32. PubMed ID: 4000475 [Abstract] [Full Text] [Related]
10. Enhanced detection of nucleus basalis magnocellularis lesion-induced spatial learning deficit in rats by modification of training regimen. Mandel RJ, Gage FH, Thal LJ. Behav Brain Res; 1989 Jan 01; 31(3):221-9. PubMed ID: 2914073 [Abstract] [Full Text] [Related]
11. Sustained cortical metabolic responsivity to physostigmine after nucleus basalis magnocellularis ablation in rats. De Micheli E, Lamour Y, Bassant MH, Soncrant TT. Brain Res; 1993 Jun 25; 615(1):80-6. PubMed ID: 8364728 [Abstract] [Full Text] [Related]
12. Impairment in T-maze reinforced alternation performance following nucleus basalis magnocellularis lesions in rats. Salamone JD, Beart PM, Alpert JE, Iversen SD. Behav Brain Res; 1984 Jul 25; 13(1):63-70. PubMed ID: 6541050 [Abstract] [Full Text] [Related]
13. Anticholinergic sensitivity in the aging rat septohippocampal system as assessed in a spatial memory task. Nilsson OG, Gage FH. Neurobiol Aging; 1993 Jul 25; 14(5):487-97. PubMed ID: 8247231 [Abstract] [Full Text] [Related]
14. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Muir JL, Everitt BJ, Robbins TW. Psychopharmacology (Berl); 1995 Mar 25; 118(1):82-92. PubMed ID: 7597126 [Abstract] [Full Text] [Related]
15. Memory following cholinergic (NBM) and noradrenergic (DNAB) lesions made singly or in combination: potentiation of disruption by scopolamine. Sahgal A, Keith AB, Lloyd S, Kerwin JM, Perry EK, Edwardson JA. Pharmacol Biochem Behav; 1990 Dec 25; 37(4):597-605. PubMed ID: 2128756 [Abstract] [Full Text] [Related]
16. Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats. Santucci AC, Kanof PD, Haroutunian V. Psychopharmacology (Berl); 1989 Dec 25; 99(1):70-4. PubMed ID: 2506606 [Abstract] [Full Text] [Related]
17. Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats. Kwo-On-Yuen PF, Mandel R, Chen AD, Thal LJ. Exp Neurol; 1990 Jun 25; 108(3):221-8. PubMed ID: 2351210 [Abstract] [Full Text] [Related]
18. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis. Shinoda M, Miyazaki A, Toide K. Behav Brain Res; 1999 Feb 15; 99(1):17-25. PubMed ID: 10512568 [Abstract] [Full Text] [Related]
19. Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats. Beninger RJ, Wirsching BA, Mallet PE, Jhamandas K, Boegman RJ. Pharmacol Biochem Behav; 1995 Aug 15; 51(4):739-46. PubMed ID: 7675853 [Abstract] [Full Text] [Related]
20. Learning deficits after unilateral AF64A lesions in the rat basal forebrain: role of cholinergic and noncholinergic systems. Nakamura S, Tani Y, Maezono Y, Ishihara T, Ohno T. Pharmacol Biochem Behav; 1992 May 15; 42(1):119-30. PubMed ID: 1528935 [Abstract] [Full Text] [Related] Page: [Next] [New Search]